Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Wellbeing Digital Sciences Inc
(OP:
KONEF
)
N/A
UNCHANGED
Last Price
Updated: 3:57 PM EST, Mar 6, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Headline News about Wellbeing Digital Sciences Inc
< Previous
1
2
Next >
Wellbeing Digital Sciences' Subsidiary KGK Science Forms Tactical Partnership With Nova Mentis
January 27, 2022
The Companies Plan to Jointly Submit a Psilocybin Clinical Trial Application to Health Canada
Via
Benzinga
Psyched: Delix Raises $30M, New Ketamine Study For Alcohol Use Disorder, FDA Approves Ketamine Trial For ALS
January 18, 2022
New Awakn Study Shows Ketamine Has Potential To Treat Alcoholism Awakn Life Sciences Corp. (NEO: AWKN) (OTCQB:
Via
Benzinga
Ketamine One Shares Uplisted To OTCQB
January 12, 2022
KetamineOne Capital Limited (OTCQB:KONEF), a company ...
Via
Benzinga
Cannabis Movers & Shakers: HEXO, Agrify, MindMed, KetamineOne
December 15, 2021
Agrify Taps Barry Turkanis To Its Board Of Directors Vertically integrated cannabis company Agrify Corporation (NASDAQ...
Via
Benzinga
Cannabis Dispensary Roundup: Verano, Jushi, Cresco, KetamineOne
December 10, 2021
Verano Opens 3rd Jacksonville Area Location and 40th Florida Storefront In Orange Park Verano Holdings Corp.
Via
Benzinga
Topics
Cannabis
Exposures
Cannabis
Cannabis Dispensary Roundup: Ascend Wellness, Ketamine One, Cresco, Kiaro, TILT, BELLEBUD
November 22, 2021
Ascend Wellness Opens Second Massachusetts Store in Newton Vertically integrated cannabis company Ascend Wellness Holdings, Inc...
Via
Benzinga
Topics
Cannabis
Exposures
Cannabis
Psyched: The 50 Publicly-listed Psychedelics Companies, Atai's New Subsidiary, PharmaTher Gets New Orphan Drug Designation
October 18, 2021
The Week In Psychedelics
Via
Benzinga
Psyched: Delic Buys 10 Ketamine Clinics For $10M, Atai Launches Ibogaine Human Trials, Small Pharma Concludes Phase 1 DMT Study
September 27, 2021
The Week In Psychedelics:
Via
Benzinga
There Are Now 50 Psychedelics Companies Listed In The U.S. - Here They Are
October 13, 2021
Just two years ago, the psychedelics sector was a small research space reserved for academics and extremely forward-thinking investors. S...
Via
Benzinga
Psyched: Cybin Gets $9 Price Target, FSD Pharma Acquires Lucid, New Trials From Psilera, Awakn, PharmaDrug And Braxia, California Bill Put On Hold
August 30, 2021
Contents
Via
Benzinga
KetamineOne Capital Forms Medical Advisory Board, Will Oversee Development Of Its Mental-Health Platform
August 23, 2021
KetamineOne Capital Limited (NEO: MEDI) (OTCPK:
Via
Benzinga
< Previous
1
2
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.